ICD-10 Coding for BRCA2 Positive(Z15.01, Z15.02)
Complete ICD-10-CM coding and documentation guide for BRCA2 Positive. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to BRCA2 Positive
Z15-Z15.09Primary Range
Genetic susceptibility to malignant neoplasm
This range includes codes for genetic susceptibility to cancer, specifically Z15.01 for BRCA2 related breast cancer risk.
Family history of primary malignant neoplasm
This range includes codes for family history of cancer, which can be used as ancillary codes to support BRCA2 documentation.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| Z15.01 | Genetic susceptibility to malignant neoplasm of breast | Use when a patient has a confirmed BRCA2 mutation that increases breast cancer risk. |
|
| Z15.02 | Genetic susceptibility to malignant neoplasm of ovary | Use when a patient has a confirmed BRCA2 mutation that increases ovarian cancer risk. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for BRCA2 positive
Essential facts and insights about BRCA2 Positive
Primary ICD-10-CM Codes for brca2 positive
Decision Criteria
clinical Criteria
- Confirmed BRCA2 mutation with increased breast cancer risk
Applicable To
- BRCA2 mutation with breast cancer risk
Excludes
- Genetic susceptibility to malignant neoplasm of ovary (Z15.02)
Clinical Validation Requirements
- Confirmed BRCA2 mutation via genetic testing
- Risk assessment using models like Tyrer-Cuzick
Code-Specific Risks
- Incorrectly using Z14.8 instead of Z15.01
Coding Notes
- Ensure genetic testing results are documented to support the use of Z15.01.
Z15.02 - Genetic susceptibility to malignant neoplasm of ovary
Use when a patient has a confirmed BRCA2 mutation that increases ovarian cancer risk.
Applicable To
- BRCA2 mutation with ovarian cancer risk
Excludes
- Genetic susceptibility to malignant neoplasm of breast (Z15.01)
Clinical Validation Requirements
- Confirmed BRCA2 mutation via genetic testing
- Risk assessment using models like Penn II
Coding Notes
Ensure genetic testing results are documented to support the use of Z15.02.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting BRCA2 Positive to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code Z15.01.
Impact
Clinical: Incomplete risk assessment, Regulatory: Non-compliance with documentation standards, Financial: Potential claim denials
Mitigation Strategy
Always document family history when relevant, Use templates to ensure completeness
Impact
Reimbursement: Incorrect coding may lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate patient records and data reporting.
Mitigation Strategy
Use Z15.01 specifically for BRCA2 mutations related to breast cancer risk.
Impact
Incomplete documentation of genetic testing results can lead to audit findings.
Mitigation Strategy
Ensure all genetic test results and risk assessments are fully documented.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for BRCA2 Positive, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for BRCA2 Positive
Use these documentation templates to ensure complete and accurate documentation for BRCA2 Positive. These templates include all required elements for proper coding and billing.
BRCA2 Positive with Family History
Specialty: OncologyRequired Elements
- Genetic test results
- Family history details
- Risk assessment scores
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for BRCA2 Positive? Ask your questions below.